Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment (vol 60, pg 23, 2023)

Terzi, MuratHelvaci, Elif MerveSen, SedatBoz, CavitCilingir, VedatAkcali, AylinBeckmann, Yesim2025-01-272025-01-2720231300-06671309-4866https://doi.org/10.29399/npa.28499https://hdl.handle.net/20.500.12428/28706[Anstract Not Available]eninfo:eu-repo/semantics/openAccessClinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment (vol 60, pg 23, 2023)Correction60219019010.29399/npa.28499Q4WOS:00102164210001737287556